Identification of novel compounds against three targets of SARS CoV-2 coronavirus by combined virtual screening and supervised machine learning

Coronavirus disease 2019 (COVID-19) is a major threat worldwide due to its fast spreading. As yet, there are no established drugs available. Speeding up drug discovery is urgently required. We applied a workflow of combined in silico methods (virtual drug screening, molecular docking and supervised...

Descripción completa

Detalles Bibliográficos
Autores principales: Kadioglu, Onat, Saeed, Mohamed, Greten, Henry Johannes, Efferth, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8008812/
https://www.ncbi.nlm.nih.gov/pubmed/33845270
http://dx.doi.org/10.1016/j.compbiomed.2021.104359

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8008812/
https://www.ncbi.nlm.nih.gov/pubmed/33845270
http://dx.doi.org/10.1016/j.compbiomed.2021.104359

Ejemplares similares